JG
TNDM icon

Jefferies Group’s Tandem Diabetes Care TNDM Stock Holding History

Jefferies Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,160
Closed -$651K – 3499
2015
Q1 		$651K Buy
+5,160
New +$671K ﹤0.01% 1260

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's TNDM Position: Q3 2022 in Review

Jefferies Group opened a new position in Tandem Diabetes Care (TNDM) in Q3 2022: 6,630 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #1206 among its holdings. This is a return to the name: Jefferies Group previously reported a position in TNDM as recently as Q3 2019.

Jefferies Group first reported a position in TNDM in Q1 2015 and has held it in 6 quarters since. The position peaked at $683K in Q3 2019. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Jefferies Group held 6,630 shares of Tandem Diabetes Care worth $317K as of Q3 2022.
  • Tandem Diabetes Care was a new Jefferies Group position in Q3 2022.
  • Tandem Diabetes Care made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1206 holding.
  • Jefferies Group first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 6 quarters since.
  • Jefferies Group's Tandem Diabetes Care position peaked at $683K in Q3 2019.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.